The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.
Not Applicable
- Conditions
- The CKD patients with type 2 diabetes
- Registration Number
- JPRN-UMIN000011101
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) diabetic ketoacidosis, diabetic coma, type 1 diabetes 2) with severe liver dysfunction 3) severe infection, before and after surgery, severe trauma 4) end-stage renal failure during dialysis or severe renal dysfunction (CrCl under 30ml/min) 5) pregnant 6) patients with a history of hypersensitivity to any component of this drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method